L6795

LY311727

≥98% (HPLC), powder

• Fórmula empírica (notación de Hill): C₂₂H₂₇N₂O₅P
• Número de CAS: 164083-84-5
• Peso molecular: 430.43
• MDL number: MFCD00943218
• UNSPSC Code: 41106300
• PubChem Substance ID: 329817644
• NACRES: NA.77

Propiedades

• Quality Level: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to tan
• solubility: DMSO: ≥15 mg/mL
• originator: Eli Lilly
• storage temp.: 2-8°C
• SMILES string: CCc1c(CC(N)=O)c2cc(OCCCP(O)(O)=O)ccc2n1Cc3ccccc3
• InChI: 1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28)
• InChI key: OPWQYOUZRHDKBR-UHFFFAOYSA-N

Descripción

Biochem/physiol Actions

LY311727 is an orally active; potent secretory Phospholipase A2 (sPLA2; Group IIa) inhibitor.

Features and Benefits

This compound is featured on the Phospholipase A2 page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Eli Lilly. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable